Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Brazil ends retinol survey, screening to follow:

This article was originally published in Clinica

Executive Summary

Brazil's healthcare regulatory authority - Agencia Nacional de Vigilancia Sanitaria (Anvisa) - has concluded its survey of laboratories capable of performing serum retinol testing, as part of a national exercise to map iron-deficiency anaemia. The survey conducted for the national network of pathology laboratories (Reblas) ended on January 30, after having been extended at least twice since its launch in early October 2004 (see Clinica No 1129, p 13); its initial deadline was mid-November. The chosen laboratories will be contracted to support the screening exercise, which will involve 5,000 women aged 15-49 years and 5,000 children under the age of five; Anvisa has not announced further details.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts